Tapewire

Nasdaq · USD

TDAC

Translational Development Acquisition Corp.

Export transactions ↓
Tapewire entity
6290
SEC CIK
0001926599
Parsed reports
8

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 27, 2026 Filed May 29, 2026 20:05 UTC
Hoffman Michael BDirector · Chairman and CEO
PurchaseWarrants · Derivative 53,395 $0.79 Strike: $11.50 $42,278.16
Disclosure

SEC source: 0001104659-26-068236 · tm2616067-1_4seq1.xml · derivative · entry 1

Hoffman Michael B · CIK 0001290208 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,395

Underlying: Class A ordinary shares · 53,395 shares

Expires not disclosed

F2 · price: The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.71 to $0.9997, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth in this footnote. For reference, aggregate proceeds were $42,280.50 and the exact weighted average price was $0.7918438056.

F1 · derivative.exercise_date: Each warrant becomes exercisable 30 days after completion of the Issuer's initial business combination, as described in the Issuer's filings with the Securities and Exchange Commission. The warrants expire five years after completion of the Issuer's initial business combination, or earlier upon redemption or liquidation, as described in the Issuer's filings with the Securities and Exchange Commission (the "SEC")

F1 · derivative.expiration_date: Each warrant becomes exercisable 30 days after completion of the Issuer's initial business combination, as described in the Issuer's filings with the Securities and Exchange Commission. The warrants expire five years after completion of the Issuer's initial business combination, or earlier upon redemption or liquidation, as described in the Issuer's filings with the Securities and Exchange Commission (the "SEC")

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.